Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
Moxalactam was used as initial, empirical therapy in 69 patients with a variety of serious bacterial infections, 32% of which were accompanied by bacteremia. Overall, the success rate was 83% and drug-related adverse effects were minimal. The drug was less efficacious in infections caused by aerobic...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1983
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC184702/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6222696/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.23.4.565 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|